These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Indications and use of therapeutic component separation].
    Author: Tilz GP, Vollmann H, Lanzer G, Teubl I.
    Journal: Med Klin; 1978 Sep 29; 73(39):1351-5. PubMed ID: 703660.
    Abstract:
    Therapeutic component separation: Clinical indications and applications. This original communication describes clinical indications, applications and results of the component separation. We have used the Hemonetics cell-separator designed for a discontinuous separation procedure. By this means component separation was rapid and plasma-exchange efficient, which offers a promising way for symptomatic treatment when a qualitative or quantitative modification of the composition of the blood is wanted (e.g. diminuation of hyperviscosity, modifications of circulating immune complexes, elimination of toxic antibodies and protein bound toxins). Component separation represents a step forward to supportive treatment and immunological reconstitution.
    [Abstract] [Full Text] [Related] [New Search]